Bridgewater Associates, LP
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1350694
Westport, CT
Position in PBH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,193,658
+$1,591,062 QoQ
Shares Held
46,407
+380.6% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 318 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. PBH ranks #12 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
866,285 | $4,270,785 |
All Filings in PBH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,193,658 | 46,407 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $602,596 | 9,657 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||